Table of Contents

1 Report Overview

• 1.1 Definition and Specification
• 1.2 Report Overview
  • 1.2.1 Manufacturers Overview
  • 1.2.2 Regions Overview
  • 1.2.3 Type Overview
  • 1.2.4 Application Overview
• 1.3 Industrial Chain
  • 1.3.1 Compounding Pharmacy Overall Industrial Chain
  • 1.3.2 Upstream
  • 1.3.3 Downstream
• 1.4 Industry Situation
  • 1.4.1 Industrial Policy
  • 1.4.2 Product Preference
  • 1.4.3 Economic/Political Environment
• 1.5 SWOT Analysis

2 Market Analysis by Types

• 2.1 Overall Market Performance(Volume)
  • 2.1.1 Pharmaceutical Ingredient Alteration (PIA) Market Performance (Volume)
  • 2.1.2 Currently Unavailable Pharmaceutical Manufacturing (CUPM) Market Performance (Volume)
  • 2.1.3 Pharmaceutical Dosage Alteration (PDA) Market Performance (Volume)
  • 2.1.4 Others Market Performance (Volume)
• 2.2 Overall Market Performance(Value)
  • 2.2.1 Pharmaceutical Ingredient Alteration (PIA) Market Performance (Value)
  • 2.2.2 Currently Unavailable Pharmaceutical Manufacturing (CUPM) Market Performance (Value)
  • 2.2.3 Pharmaceutical Dosage Alteration (PDA) Market Performance (Value)
  • 2.2.4 Others Market Performance (Value)

3 Product Application Market

• 3.1 Overall Market Performance (Volume)
  • 3.1.1 Adult Market Performance (Volume)
  • 3.1.2 Pediatric Market Performance (Volume)
  • 3.1.3 Geriatric Market Performance (Volume)
  • 3.1.4 Veterinary Market Performance (Volume)

4 Manufacturers Profiles/Analysis

• 4.1 Fagron
  • 4.1.1 Fagron Profiles
  • 4.1.2 Fagron Product Information
  • 4.1.3 Fagron Compounding Pharmacy Business Performance
  • 4.1.4 Fagron Compounding Pharmacy Business Development and Market Status
• 4.2 Wedgewood Pharmacy
  • 4.2.1 Wedgewood Pharmacy Profiles
  • 4.2.2 Wedgewood Pharmacy Product Information
  • 4.2.3 Wedgewood Pharmacy Compounding Pharmacy Business Performance
  • 4.2.4 Wedgewood Pharmacy Compounding Pharmacy Business Development and Market Status
• 4.3 CAPS
  • 4.3.1 CAPS Profiles
  • 4.3.2 CAPS Product Information
  • 4.3.3 CAPS Compounding Pharmacy Business Performance
  • 4.3.4 CAPS Compounding Pharmacy Business Development and Market Status
• 4.4 FreseniusKabi
  • 4.4.1 FreseniusKabi Profiles
  • 4.4.2 FreseniusKabi Product Information
  • 4.4.3 FreseniusKabi Compounding Pharmacy Business Performance
  • 4.4.4 FreseniusKabi Compounding Pharmacy Business Development and Market Status
• 4.5 Advanced Pharma
  • 4.5.1 Advanced Pharma Profiles
  • 4.5.2 Advanced Pharma Product Information
  • 4.5.3 Advanced Pharma Compounding Pharmacy Business Performance
  • 4.5.4 Advanced Pharma Compounding Pharmacy Business Development and Market Status
• 4.6 PharMEDiumServices
  • 4.6.1 PharMEDiumServices Profiles
  • 4.6.2 PharMEDiumServices Product Information
  • 4.6.3 PharMEDiumServices Compounding Pharmacy Business Performance
  • 4.6.4 PharMEDiumServices Compounding Pharmacy Business Development and Market Status
• 4.7 Cantrell Drug
  • 4.7.1 Cantrell Drug Profiles
  • 4.7.2 Cantrell Drug Product Information
  • 4.7.3 Cantrell Drug Compounding Pharmacy Business Performance
  • 4.7.4 Cantrell Drug Compounding Pharmacy Business Development and Market Status
• 4.8 Dougherty’s Pharmacy
  • 4.8.1 Dougherty’s Pharmacy Profiles
  • 4.8.2 Dougherty’s Pharmacy Product Information
  • 4.8.3 Dougherty’s Pharmacy Compounding Pharmacy Business Performance
  • 4.8.4 Dougherty’s Pharmacy Compounding Pharmacy Business Development and Market Status
• 4.9 Institutional Pharmacy Solutions
  • 4.9.1 Institutional Pharmacy Solutions Profiles
  • 4.9.2 Institutional Pharmacy Solutions Product Information
  • 4.9.3 Institutional Pharmacy Solutions Compounding Pharmacy Business Performance
  • 4.9.4 Institutional Pharmacy Solutions Compounding Pharmacy Business Development and Market Status
• 4.10 Lorraine'sPharmacy
  • 4.10.1 Lorraine'sPharmacy Profiles
  • 4.10.2 Lorraine'sPharmacy Product Information
  • 4.10.3 Lorraine'sPharmacy Compounding Pharmacy Business Performance
  • 4.10.4 Lorraine'sPharmacy Compounding Pharmacy Business Development and Market Status
• 4.11 Triangle Compounding Pharmacy
• 4.12 Village Compounding Pharmacy
• 4.13 Olympia Pharmacy
• 4.14 B. Braun Medical
• 4.15 ITC Compounding Pharmacy
• 4.16 Pencol Compounding Pharmacy

5 Market Performance for Manufacturers

• 5.1 Europe Compounding Pharmacy Sales (K Units) and Market Share by Manufacturers 2014-2020
• 5.2 Europe Compounding Pharmacy Revenue (M USD) and Market Share by Manufacturers 2014-2020
• 5.3 Europe Compounding Pharmacy Price (USD/Unit) of Manufacturers 2014-2020
• 5.4 Europe Compounding Pharmacy Gross Margin of Manufacturers 2014-2020
• 5.5 Market Concentration

6 Regions Market Performance for Manufacturers

• 6.1 Germany Market Performance for Manufacturers
  • 6.1.1 Germany Compounding Pharmacy Sales (K Units) and Share of Manufacturers 2014-2020
  • 6.1.2 Germany Compounding Pharmacy Revenue (M USD) and Share of Manufacturers 2014-2020
  • 6.1.3 Germany Compounding Pharmacy Price (USD/Unit) of Manufacturers 2014-2020
  • 6.1.4 Germany Compounding Pharmacy Gross Margin of Manufacturers 2014-2020
  • 6.1.5 Market Concentration
• 6.2 UK Market Performance for Manufacturers
  • 6.2.1 UK Compounding Pharmacy Sales (K Units) and Share of Manufacturers 2014-2020
  • 6.2.2 UK Compounding Pharmacy Revenue (M USD) and Share of Manufacturers 2014-2020
  • 6.2.3 UK Compounding Pharmacy Price (USD/Unit) of Manufacturers 2014-2020
  • 6.2.4 UK Compounding Pharmacy Gross Margin of Manufacturers 2014-2020
  • 6.2.5 Market Concentration
• 6.3 France Market Performance for Manufacturers
  • 6.3.1 France Compounding Pharmacy Sales (K Units) and Share of Manufacturers 2014-2020
  • 6.3.2 France Compounding Pharmacy Revenue (M USD) and Share of Manufacturers 2014-2020
  • 6.3.3 France Compounding Pharmacy Price (USD/Unit) of Manufacturers 2014-2020
  • 6.3.4 France Compounding Pharmacy Gross Margin of Manufacturers 2014-2020
  • 6.3.5 Market Concentration
• 6.4 Russia Market Performance for Manufacturers
  • 6.4.1 Russia Compounding Pharmacy Sales (K Units) and Share of Manufacturers 2014-2020
  • 6.4.2 Russia Compounding Pharmacy Revenue (M USD) and Share of Manufacturers 2014-2020
  • 6.4.3 Russia Compounding Pharmacy Price (USD/Unit) of Manufacturers 2014-2020
  • 6.4.4 Russia Compounding Pharmacy Gross Margin of Manufacturers 2014-2020
  • 6.4.5 Market Concentration
• 6.5 Benelux Market Performance for Manufacturers
  • 6.5.1 Benelux Compounding Pharmacy Sales (K Units) and Share of Manufacturers 2014-2020
  • 6.5.2 Benelux Compounding Pharmacy Revenue (M USD) and Share of Manufacturers 2014-2020
  • 6.5.3 Benelux Compounding Pharmacy Price (USD/Unit) of Manufacturers 2014-2020
  • 6.5.4 Benelux Compounding Pharmacy Gross Margin of Manufacturers 2014-2020
  • 6.5.5 Market Concentration
• 6.6 Italy Market Performance for Manufacturers
  • 6.6.1 Italy Compounding Pharmacy Sales (K Units) and Share of Manufacturers 2014-2020
  • 6.6.2 Italy Compounding Pharmacy Revenue (M USD) and Share of Manufacturers 2014-2020
  • 6.6.3 Italy Compounding Pharmacy Price (USD/Unit) of Manufacturers 2014-2020
  • 6.6.4 Italy Compounding Pharmacy Gross Margin of Manufacturers 2014-2020
  • 6.6.5 Market Concentration
• 6.7 Spain Market Performance for Manufacturers
  • 6.7.1 Spain Compounding Pharmacy Sales (K Units) and Share of Manufacturers 2014-2020
  • 6.7.2 Spain Compounding Pharmacy Revenue (M USD) and Share of Manufacturers 2014-2020
  • 6.7.3 Spain Compounding Pharmacy Price (USD/Unit) of Manufacturers 2014-2020
  • 6.7.4 Spain Compounding Pharmacy Gross Margin of Manufacturers 2014-2020
  • 6.7.5 Market Concentration
• 6.8 Market Performance for Manufacturers
  • 6.8.1 Compounding Pharmacy Sales (K Units) and Share of Manufacturers 2014-2020
  • 6.8.2 Compounding Pharmacy Revenue (M USD) and Share of Manufacturers 2014-2020
  • 6.8.3 Compounding Pharmacy Price (USD/Unit) of Manufacturers 2014-2020
  • 6.8.4 Compounding Pharmacy Gross Margin of Manufacturers 2014-2020
  • 6.8.5 Market Concentration

7 Europe Compounding Pharmacy Market Performance (Sales Point)

• 7.1 Europe Compounding Pharmacy Sales (K Units) and Market Share by Regions 2014-2020
• 7.2 Europe Compounding Pharmacy Revenue (M USD) and Market Share by Regions 2014-2020
• 7.3 Europe Compounding Pharmacy Price (USD/Unit) by Regions 2014-2020
• 7.4 Europe Compounding Pharmacy Gross Margin by Regions 2014-2020

8 Development Trend for Regions (Sales Point)

• 8.1 Europe Compounding Pharmacy Sales and Growth, Sales Value and Growth Rate2014-2020
• 8.2 Germany Compounding Pharmacy Sales and Growth, Sales Value and Growth Rate2014-2020
• 8.3 UK Compounding Pharmacy Sales and Growth, Sales Value and Growth Rate2014-2020
• 8.4 France Compounding Pharmacy Sales and Growth, Sales Value and Growth Rate2014-2020
• 8.5 Russia Compounding Pharmacy Sales and Growth, Sales Value and Growth Rate2014-2020
• 8.6 Benelux Compounding Pharmacy Sales and Growth, Sales Value and Growth Rate2014-2020
• 8.7 Italy Compounding Pharmacy Sales and Growth, Sales Value and Growth Rate2014-2020
• 8.8 Spain Compounding Pharmacy Sales and Growth, Sales Value and Growth Rate2014-2020

9 Upstream Source, Technology and Cost

• 9.1 Upstream Source
• 9.2 Technology
• 9.3 Cost

10 Channel Analysis

• 10.1 Market Channel
• 10.2 Distributors

11 Consumer Analysis

• 11.1 Adult Industry
• 11.2 Pediatric Industry
• 11.3 Geriatric Industry
• 11.4 Veterinary Industry

12 Market Forecast 2021-2026

• 12.1 Sales (K Units), Revenue (M USD), Market Share and Growth Rate 2021-2026
  • 12.1.1 Europe Compounding Pharmacy Sales (K Units), Revenue (M USD) and Market Share by Regions 2021-2026
  • 12.1.2 Europe Compounding Pharmacy Sales (K Units) and Growth Rate 2021-2026
  • 12.1.3 Germany Compounding Pharmacy Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
  • 12.1.4 UK Compounding Pharmacy Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
  • 12.1.5 France Compounding Pharmacy Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
  • 12.1.6 Russia Compounding Pharmacy Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
  • 12.1.7 Benelux Compounding Pharmacy Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
  • 12.1.8 Italy Compounding Pharmacy Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
  • 12.1.9 Spain Compounding Pharmacy Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
• 12.2 Sales (K Units) and Revenue (M USD) Forecast by Types 2021-2026
  • 12.2.1 Overall Market Performance
  • 12.2.2 Pharmaceutical Ingredient Alteration (PIA) Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
  • 12.2.3 Currently Unavailable Pharmaceutical Manufacturing (CUPM) Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
  • 12.2.4 Pharmaceutical Dosage Alteration (PDA) Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
  • 12.2.5 Others Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
• 12.3 Sales Forecast by Application 2021-2026
  • 12.3.1 Overall Market Performance
  • 12.3.2 Adult Sales and and Growth Rate 2021-2026
  • 12.3.3 Pediatric Sales and and Growth Rate 2021-2026
  • 12.3.4 Geriatric Sales and and Growth Rate 2021-2026
  • 12.3.5 Veterinary Sales and and Growth Rate 2021-2026
• 12.4 Price (USD/Unit) and Gross Profit Forecast
  • 12.4.1 Europe Compounding Pharmacy Price (USD/Unit) Trend 2021-2026
  • 12.4.2 Europe Compounding Pharmacy Gross Profit Trend 2021-2026

13 Conclusion

In this report, the Compounding Pharmacy market is expected to be valued at USD xxx billion by 2026, growing at a CAGR of xx% between 2020 and 2026. In this study, sales and sales value (million USD) of major players in Europe market will be included.
Sales and revenue by type/application from 2014-2026.
Industry chain, market trend, downstream and upstream information is also included.

Geographically, this report split Europe into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Compounding Pharmacy for these regions, from 2014 to 2026 (forecast), including
Germany
UK
France
Russia
Benelux
Italy
Spain

Europe Compounding Pharmacy market competition by top manufacturers/players, with Compounding Pharmacy sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
Fagron
Wedgewood Pharmacy
CAPS
FreseniusKabi
Advanced Pharma
PharMEDiumServices
Cantrell Drug
Dougherty’s Pharmacy
Institutional Pharmacy Solutions
Lorraine'sPharmacy
Triangle Compounding Pharmacy
Village Compounding Pharmacy
Olympia Pharmacy
B. Braun Medical
ITC Compounding Pharmacy
Pencol Compounding Pharmacy

On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into
Pharmaceutical Ingredient Alteration (PIA)
Currently Unavailable Pharmaceutical Manufacturing (CUPM)
Pharmaceutical Dosage Alteration (PDA)
Others

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Units), market share and growth rate of Compounding Pharmacy for each application, including
Adult
Pediatric
Geriatric
Veterinary

If you have any special requirements, please let us know and we will offer you the report as you want.